It has been reported that tumor cells could exploit multiple mechanisms of escaping immune surveillance, such as upregulating the expression of the major histocompatibility complex (MHC) or downregulating the expression of negative immune checkpoint factors.298. This evidence concerns the gene HLA-C and neoplasm.